Astellas Pharma Inc 4503.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 3:00 PM JST
1,923.50quote price arrow down-9.00 (-0.47%)
Volume
6,100,900
52 week range
1,782.00 - 2,205.00
Loading...
  • Open1,919.00
  • Day High1,931.50
  • Day Low1,919.00
  • Prev Close1,932.50
  • 52 Week High2,205.00
  • 52 Week High Date07/27/22
  • 52 Week Low1,782.00
  • 52 Week Low Date03/15/22

Key Stats

  • Market Cap26,279.19M
  • Shares Out1,822.81M
  • 10 Day Average Volume5.44M
  • Dividend60.00
  • Dividend Yield3.12%
  • Beta-
  • YTD % Change-4.14

KEY STATS

  • Open1,919.00
  • Day High1,931.50
  • Day Low1,919.00
  • Prev Close1,932.50
  • 52 Week High2,205.00
  • 52 Week High Date07/27/22
  • 52 Week Low1,782.00
  • 52 Week Low Date03/15/22
  • Market Cap26,279.19M
  • Shares Out1,822.81M
  • 10 Day Average Volume5.44M
  • Dividend60.00
  • Dividend Yield3.12%
  • Beta-
  • YTD % Change-4.14

RATIOS/PROFITABILITY

  • EPS (TTM)83.60
  • P/E (TTM)23.01
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/29/2022
  • Div Amount30.00
  • Split Date-
  • Split Factor-

Latest On Astellas Pharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Kenji Yasukawa
President, Chief Executive Officer, Representative Director
Minoru Kikuoka
Chief Financial Officer, Senior Managing Executive Officer
Naoki Okamura
Vice President, Chief Strategy Officer, Representative Director
Address
2-5-1, Nihombashihon-cho
Chuo-ku, TKY
103-8411
Japan